Skip to main content
. 2022 Mar 21;9:842532. doi: 10.3389/fcvm.2022.842532

Table 2.

Cancer treatment and metastatic stage.

Variable (n = 51)
Doxorubicin 51 (100%)
Cyclophosphamide 51 (100%)
Trastuzumab 7 (13.7)
Paclitaxel 45 (88.2)
Cisplatin 1 (2)
Radiotherapy 45 (88.2)
Surgery 28 (54)
Metastatic Stage 2 (3.9)

Data are expressed as number (percentage).